Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients

  • F. Sherif
  • L. Eriksson
  • L. Oreland


The activity of gamma-aminobutyrate aminotransferase (GABA-T) was estimated in twelve regions of brains from 22 control subjects and 6 cases with schizophrenia. In the controls, no significant correlation was found between the enzyme activity and age or postmortem interval (PMI) in any of the brain regions studied. In experiments on rat brains, the enzyme activity decreased about 20% during the first 2 hours of storage at room temperature and at 4° C but remained steady thereafter. A similar initial decline in activity in the human brain material cannot be excluded. In the human brains, a slightly lower activity was found in the group below 75 years (n=8) when compared with the group above 75 years (n=8). A tendency to higher activities was found in female brains (n=10) compared with male brains (n=12). No significant difference in the enzyme activity was found between schizophrenic brains, in any of the regions studied, when compared to controls, matched for age, sex and PMI.


Aminobutyrate aminotransferase schizophrenia postmortem brain 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (DSM-III), 3rd ed. APA, Washington DCGoogle Scholar
  2. Battistin L, Varotto M, Berlese G, Roman G (1984) Effects of some anticonvulsant drugs on brain GABA level and GAD and GABA-T activities. Neurochem Res 9: 225–231PubMedGoogle Scholar
  3. Bird ED, Barnes J, Iversen LI, Spokes EG, Mackay AVP, Shepherd M (1977) Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl-transferase activity in schizophrenia and related psychoses. Lancet ii: 1157–1159Google Scholar
  4. Bolton JB, Rimmer E, Williams J, Richens A (1989) The effect of vigabatrin on brain and platelet GABA-transaminase activities. Br J Clin Pharmacol [Suppl] 27: 35–42Google Scholar
  5. Cross AJ, Crow TJ, Owen F (1979) Gamma-aminobutyric acid in the brain in schizophrenia. Lancet i: 560–561Google Scholar
  6. Emson PC (1976) Effects of chronic treatment with aminooxyacetic acid or sodium n-diprophyl acetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats. J Neurochem 27: 1489–1494PubMedGoogle Scholar
  7. Fariello RG, Ticku MK (1983) The prespective of GABA replenishment therapy in the epilepsies: a critical evaluation of hopes and concerns. Life Sci 33: 1629–1640PubMedGoogle Scholar
  8. Fibiger HC, Lloyd KG (1984) Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. TINS 12: 462–464Google Scholar
  9. Gale K (1989) GABA in epilepsy: the pharmacology basis. Epilepsia 30: 1–11PubMedGoogle Scholar
  10. Gerner RH, Hare TA (1981) CSF GABA in normal subjects and patients with depression, schizophrenia, mania and anorexia nervosa. Am J Psychiatry 318: 1098–1101Google Scholar
  11. Gerner RH, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M, Hare TA, Shaywitz BA, Cohen DJ (1984) CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am J Psychiatry 141: 1533–1540PubMedGoogle Scholar
  12. Gold BI, Bowers MB, Roth RH, Sweeney DW (1980) GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137: 362–364PubMedGoogle Scholar
  13. Jeremiah S, Povey S (1981) The biochemical genetics of human gamma-aminobutyric acid transaminase. Ann Hum Genet 45: 231–236PubMedGoogle Scholar
  14. Lai H (ed) (1980) GABA neurotransmission: current developments in physiology and neurochemistry. Brain Res Bull [Suppl 2]: 5Google Scholar
  15. Lancaster G, Mohyuddin F, Scriver CR, Whelan DT (1973) A gamma-aminobutyrate pathway in mammalian kidney cortex. Biochim Biophys Acta 297: 229–240PubMedGoogle Scholar
  16. Lloyd KG, Morseli PL (1987) Psychopharamacology of GABA-ergic drugs. In: Meltzer HJ (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 183–195Google Scholar
  17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the folin phenol reagent. J Biol Chem 193: 265–275PubMedGoogle Scholar
  18. Löscher W, Hönack D, Gramer M (1989) Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a réévaluation of aminooxyacetic acid. J Neurochem 53: 1737–1750PubMedGoogle Scholar
  19. Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210PubMedGoogle Scholar
  20. McCarthy BW, Gomes UR, Neethling AC, Shanley BC, Taljaard JJF, Potgieter L, Roux JT (1981) Gamma-aminobutyric acid concentration in cerebrospinal fluid in schizophrenia. J Neurochem 36(4): 1406–1408PubMedGoogle Scholar
  21. Meldrum BS (1989) GABA-ergic mechanisms in the pathogenesis and treatment of epilepsy. Br J Clin Pharmacol 27 [Suppl]: 3–11Google Scholar
  22. Metcalf BW (1979) Inhibitors of GABA metabolism. Biochem Pharamcol 28: 1705–1712Google Scholar
  23. Palfreyman MG, Bohlen P, Huot S, Mellet M (1980) The effect of gamma-vinyl GABA and gamma-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat. Brain Res 190: 288–292PubMedGoogle Scholar
  24. Perry EK, Gibson PH, Blessed G, Perry RH, Tomlison BE (1977) Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sci 34: 247–265PubMedGoogle Scholar
  25. Perry TL, Kish SJ, Buchanan J, Hansen S (1979) Gamma-aminobutyric acid deficiency in brain of schizophrenic patients. Lancet i: 237–239Google Scholar
  26. Perry TL, Hansen S, Jones K (1989) Schizophrenia, tardive dyskinesia, and brain GABA. Biol Psychiatry 25: 200–206PubMedGoogle Scholar
  27. Pitt FN Jr, Quick C, Robins E (1965) The enzymatic measurements of gamma-aminobutyric-alpha-oxoglutaric transaminase. J Neurochem 12: 93–101PubMedGoogle Scholar
  28. Rimmer E, Kongola G, Richens A (1988) Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug. Br J Clin Pharmacol 25: 251–259PubMedGoogle Scholar
  29. Roberts E (1972) An hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosci Res Prog Bull 10: 468–483Google Scholar
  30. Roberts E, Frankel S (1950) Gamma-aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 187: 55–63PubMedGoogle Scholar
  31. Sherif F, Eriksson L, Oreland L (1991) GABA-transaminase activity in rat and human brain; regional age and sex-related differences. J Neural Transm [Gen Sect] 84: 95–102Google Scholar
  32. Spokes EG, Garrett NJ, Rosser MN, Iversen LL (1980) Distribution of GABA in postmortem brain tissue from control, psychotic and Huntington's chorea subjects. J Neurol Sci 48: 303–313PubMedGoogle Scholar
  33. Urquhart N, Perry TL, Hansen S, Kennedy J (1975) GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects. J Neurochem 24: 1071–1075PubMedGoogle Scholar
  34. van Kammen DP (1977) Gamma-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 134: 138–143PubMedGoogle Scholar
  35. van Kämmen DP, Sternberg DE, Hare TA, Waters RN, Bunney WE (1982) CSF levels of gamma-aminobutyric acid in schizophrenia. Arch Gen Psychiatry 39: 91–97PubMedGoogle Scholar
  36. Vasil'ev VY, Eremin VP, Severin ES, Sytinskii IA (1973) Comparative characterization of porcine kidney and liver gamma-aminobutyrate-glutamate-transaminases. Biokhimiya 38: 355–364Google Scholar
  37. White HL (1979) 4-Aminobutyrate: 2-oxoglutarate aminotransferase in blood platelets. Science 205: 696–698PubMedGoogle Scholar
  38. White HL, Sato TL (1978) GABA-transaminases of human brain and peripheral tissueskinetic and molecular properties. J Neurochem 31: 41–47PubMedGoogle Scholar
  39. White HL, Faison LD (1980) GABA-T in blood platelets: comparison with GABA-T of other tissues. Brain Res Bull 5: 115–119Google Scholar
  40. Wu J-Y, Wong E, Saito K, Roberts E, Schousboe A (1976) Properties of L-glutamate decarboxylase from brains of adult and newborn mice. J Neurochem 27: 653–659PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • F. Sherif
    • 1
  • L. Eriksson
    • 2
  • L. Oreland
    • 1
  1. 1.Department of Medical PharmacologyUniversity of UppsalaUppsalaSweden
  2. 2.Department of PathologyUniversity of UppsalaUppsalaSweden

Personalised recommendations